Authors:
Laczika, K
Mitterbauer, G
Mitterbauer, M
Knobl, P
Schwarzinger, I
Greinix, HT
Rabitsch, W
Fonatsch, C
Mannhalter, C
Lechner, K
Jaeger, U
Citation: K. Laczika et al., Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions, LEUK LYMPH, 42(5), 2001, pp. 923-931
Authors:
Rintelen, C
Pabinger, I
Bettelheim, P
Lechner, K
Kyrle, PA
Knobl, P
Schneider, B
Mannhalter, C
Citation: C. Rintelen et al., Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation, EUR J HAEMA, 67(3), 2001, pp. 165-169
Authors:
Kurz, M
Knobl, P
Kalhs, P
Greinix, HT
Hocker, P
Panzer, S
Citation: M. Kurz et al., Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test, TRANSFUSION, 41(6), 2001, pp. 771-774
Authors:
Jansen, M
Schmaldienst, S
Banyai, S
Quehenberger, P
Pabinger, I
Derfler, K
Horl, WH
Knobl, P
Citation: M. Jansen et al., Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb), BR J HAEM, 112(1), 2001, pp. 91-97
Authors:
Laczika, K
Mitterbauer, G
Weltermann, A
Knobl, P
Thalhammer-Scherrer, R
Haas, OA
Lechner, K
Jaeger, U
Citation: K. Laczika et al., Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA), LEUK LYMPH, 36(5-6), 2000, pp. 625-629
Authors:
Greinix, HT
Loidolt, H
Rabitsch, W
Schulenburg, A
Keil, F
Mitterbauer, M
Laczika, K
Lechner, K
Dieckmann, K
Fischer, G
Jager, U
Rosenmayr, A
Knobl, P
Schwarzinger, I
Hocker, P
Mannhalter, C
Hinterberger, W
Haas, OA
Fonatsch, C
Kalhs, P
Citation: Ht. Greinix et al., Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia, ANN HEMATOL, 79(4), 2000, pp. 206-213
Authors:
Schmaldienst, S
Goldammer, A
Spitzauer, S
Derfler, K
Horl, WH
Knobl, P
Citation: S. Schmaldienst et al., Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption, AM J KIDNEY, 36(3), 2000, pp. 490-497
Authors:
Schulenburg, A
Kalhs, P
Worel, N
Hocker, P
Knobl, P
Greinix, HT
Citation: A. Schulenburg et al., Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases, BONE MAR TR, 25(2), 2000, pp. 223-224
Authors:
Exner, M
Thalhammer, R
Kapiotis, S
Mitterbauer, G
Knobl, P
Haas, OA
Jager, U
Schwarzinger, I
Citation: M. Exner et al., The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?, CYTOMETRY, 42(2), 2000, pp. 106-109
Authors:
Geissler, K
Gisslinger, H
Knobl, P
Sperr, W
Valent, P
Dieckmann, K
Chott, A
Potter, R
Lechner, K
Jager, U
Citation: K. Geissler et al., Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience, WIEN KLIN W, 112(14), 2000, pp. 624-628
Authors:
Worel, N
Greinix, HT
Schneider, B
Kurz, M
Rabitsch, W
Knobl, P
Reiter, E
Derfler, K
Fischer, G
Hinterberger, W
Hocker, P
Kalhs, P
Citation: N. Worel et al., Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems, TRANSFUSION, 40(5), 2000, pp. 543-550
Authors:
Kurz, M
Eichelberger, B
Greinix, H
Hocker, P
Kahls, P
Knobl, P
Mayr, WR
Panzer, S
Citation: M. Kurz et al., Platelet antibodies and fever: Their association in multitransfused patients with hemato-oncological diseases, INFUSIONSTH, 26(1), 1999, pp. 34-36
Authors:
Meidlinger, P
Knobl, P
Jager, U
Gisslinger, H
Pabinger, I
Weltermann, A
Lechner, K
Geissler, K
Citation: P. Meidlinger et al., Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment, ANN HEMATOL, 78(7), 1999, pp. 299-304
Authors:
Stohlawetz, P
Stiegler, G
Knobl, P
Hocker, P
Panzer, S
Citation: P. Stohlawetz et al., The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions, ANN HEMATOL, 78(6), 1999, pp. 271-273
Authors:
Heis, N
Rintelen, C
Gisslinger, B
Knobl, P
Lechner, K
Gisslinger, H
Citation: N. Heis et al., The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera, EUR J HAEMA, 62(1), 1999, pp. 27-31